Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brass, L. M.
Right arrow Articles by Mohr, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brass, L. M.
Right arrow Articles by Mohr, J. P.

Stroke, Vol 22, 27-30, Copyright © 1991 by American Heart Association


ARTICLES

Middle cerebral artery blood velocity and cerebral blood flow in sickle cell disease

LM Brass, I Prohovnik, SG Pavlakis, DC DeVivo, S Piomelli and JP Mohr
Department of Psychiatry, Columbia-Presbyterian Medical Center, New York.

To understand better the relationship between blood velocity measured by transcranial Doppler and cerebral blood flow measured by the 133Xe inhalation method, we examined 23 patients undergoing evaluation in the Comprehensive Sickle Cell Center at Columbia University. Blood velocity in the middle cerebral artery was directly related to cerebral flow (r = 0.77; p less than 0.05). A multivariate analysis in this sample made it possible to improve this correlation to account for more than 90% of the variability in cerebral blood flow by the use of transcranial Doppler measures of velocity and pulsatility along with the patient's age and hematocrit (r = 0.95; p less than 0.001). It is likely that the combination of Doppler and clinical or demographic variables in other diseases will similarly improve the quantitative estimation of cerebral blood flow.


This article has been cited by other articles:


Home page
NEJMHome page
The Optimizing Primary Stroke Prevention in Sickle
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
N. Engl. J. Med., December 29, 2005; 353(26): 2769 - 2778.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. S. Olufsen, A. Nadim, and L. A. Lipsitz
Dynamics of cerebral blood flow regulation explained using a lumped parameter model
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R611 - R622.
[Abstract] [Full Text] [PDF]